Elicio Therapeutics, Inc. (ELTX) Gross margin 2020–2022
Elicio Therapeutics, Inc. (ELTX) gross margin by fiscal year — reported gross profit divided by reported revenue.
100.0%FY2022 · since FY2020: 58.7% → 100.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 100.0% | +1.5 pp |
| FY2021 | 98.5% | +39.8 pp |
| FY2020 | 58.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice